Andreas Busch - Dec 9, 2021 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
Chief Scientific Officer
Signature
/s/ Gary J. Simon, Attorney-in-Fact
Stock symbol
CYCN
Transactions as of
Dec 9, 2021
Transactions value $
$0
Form type
4
Date filed
12/10/2021, 03:32 PM
Next filing
Jan 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCN Employee Stock Option (Right to Buy) Award $0 +75K $0.00 75K Dec 9, 2021 Common Stock 75K $1.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to 2.08333% of the shares of Common Stock on each monthly anniversary of December 9, 2021.

Remarks:

Exhibit 24 - Power of Attorney